Literature DB >> 265513

Enkephalin: conformational analysis by means of empirical energy calculations.

Y Isogai, G Némethy, H A Scheraga.   

Abstract

Low-energy conformations of methionine-enkephalin were generated by means of an empirical method of computation. Many compact conformations, including those containing various standard bends, were of comparable energy. However, one conformation was found to have a potential energy about 5 kcal/mol (21 X 10(3) J/mol) below that of the large group of compact conformations. In this conformation, the 3-glycyl and 4-phenylalanyl residues form a bend of type II'. The conformation is stabilized by a hydrogen bond between the OH group of the 1-tyrosine side chain and the C==O group of 3-glycine or 4-phenylalanine. The phenylalanine and methionine side chains are relatively unrestricted. The conformation is consistent with published nuclear magnetic resonance parameters--coupling constants, temperature dependence of the chemical shift, and spin-lattice relaxation times. It is likely that the molecule undergoes a conformational change when it is bound to the receptor. Leucine-enkephalin appears to have the same conformation as its methionine homolog.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 265513      PMCID: PMC392298          DOI: 10.1073/pnas.74.2.414

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Investigation of the conformations of four tetrapeptides by nuclear magnetic resonance and circular dichroism spectroscopy, and conformational energy calculations.

Authors:  J C Howard; A Ali; H A Scheraga; F A Momany
Journal:  Macromolecules       Date:  1975 Sep-Oct       Impact factor: 5.985

2.  Isolation and structure identification of a morphine-like peptide "enkephalin" in bovine brain.

Authors:  R Simantov; H Snyder
Journal:  Life Sci       Date:  1976-04-15       Impact factor: 5.037

3.  Preferential conformation of the endogenous opiate-like pentapeptide Met-enkephalin in DMSO-D6 solution determined by high field H NMR.

Authors:  C Garbay-Jaureguiberry; B P Roques; R Oberlin
Journal:  Biochem Biophys Res Commun       Date:  1976-07-26       Impact factor: 3.575

4.  Opiate receptor affinity of peptides related to Leu-enkephalin.

Authors:  L Terenius; A Wahlström; G Lindeberg; S Karlsson; U Ragnarsson
Journal:  Biochem Biophys Res Commun       Date:  1976-07-12       Impact factor: 3.575

5.  Proton magnetic resonance studies of conformation and flexibility of enkephalin peptides.

Authors:  C R Jones; W A Gibbons; V Garsky
Journal:  Nature       Date:  1976-08-26       Impact factor: 49.962

6.  Conformation of Met5-enkephalin determined by high field PMR spectroscopy.

Authors:  B P Roques; C Garbay-Jaureguiberry; R Oberlin; M Anteunis; A K Lala
Journal:  Nature       Date:  1976-08-26       Impact factor: 49.962

7.  Chain reversals in proteins.

Authors:  P N Lewis; F A Momany; H A Scheraga
Journal:  Biochim Biophys Acta       Date:  1973-04-20

8.  Experimental calibration of a Karplus relationship in order to study the conformations of peptides by nuclear magnetic resonance.

Authors:  M T Cung; M Marraud; J Neel
Journal:  Macromolecules       Date:  1974 Sep-Oct       Impact factor: 5.985

9.  (D-Ala2)-Met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic.

Authors:  C B Pert; A Pert; J K Chang; B T Fong
Journal:  Science       Date:  1976-10-15       Impact factor: 47.728

10.  Preliminary analysis of 1H and 13C spectral and relaxation behavior in methionine-enkephalin.

Authors:  H E Bleich; J D Cutnell; A R Day; R J Freer; J A Glasel; J F McKelvy
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

View more
  21 in total

1.  Long time dynamics of Met-enkephalin: comparison of explicit and implicit solvent models.

Authors:  Min-yi Shen My; Karl F Freed
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

2.  Enhanced sampling of the molecular potential energy surface using mutually orthogonal latin squares: application to peptide structures.

Authors:  K Vengadesan; N Gautham
Journal:  Biophys J       Date:  2003-05       Impact factor: 4.033

3.  Atomically detailed folding simulation of the B domain of staphylococcal protein A from random structures.

Authors:  Jorge A Vila; Daniel R Ripoll; Harold A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-24       Impact factor: 11.205

4.  Characterization of low-energy conformational domains for Met-enkephalin.

Authors:  J J Perez; H O Villar; G H Loew
Journal:  J Comput Aided Mol Des       Date:  1992-04       Impact factor: 3.686

Review 5.  Exploring conformational space using a mean field technique with MOLS sampling.

Authors:  P Arun Prasad; V Kanagasabai; J Arunachalam; N Gautham
Journal:  J Biosci       Date:  2007-08       Impact factor: 1.826

6.  A supermolecule study of the effect of hydration on the conformational behaviour of leucine-enkephalin.

Authors:  I N Demetropoulos; N Gresh
Journal:  J Comput Aided Mol Des       Date:  1991-04       Impact factor: 3.686

7.  Conformational analysis of [Met5]-enkephalin: solvation and ionization considerations.

Authors:  L Carlacci
Journal:  J Comput Aided Mol Des       Date:  1998-03       Impact factor: 3.686

8.  A conformational analysis for leucine-enkephalin using activity and binding data of synthetic analogues.

Authors:  C R Beddell; R B Clark; L A Lowe; S Wilkinson; K J Chang; P Cuatrecasas; R Miller
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

Review 9.  MOLS sampling and its applications in structural biophysics.

Authors:  L Ramya; Shankaran Nehru Viji; Pandurangan Arun Prasad; Vadivel Kanagasabai; Namasivayam Gautham
Journal:  Biophys Rev       Date:  2010-11-16

10.  De novo structure prediction and experimental characterization of folded peptoid oligomers.

Authors:  Glenn L Butterfoss; Barney Yoo; Jonathan N Jaworski; Ilya Chorny; Ken A Dill; Ronald N Zuckermann; Richard Bonneau; Kent Kirshenbaum; Vincent A Voelz
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.